Evidence map›Paper›PMID 33462483›Full record

ArticleNature genetics2021

Genome-wide landscape of RNA-binding protein target site dysregulation reveals a major impact on psychiatric disorder risk.

Christopher Y Park, Jian Zhou, Aaron K Wong, Kathleen M Chen, Chandra L Theesfeld, Robert B Darnell, Olga G Troyanskaya

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Regulation of RNA-binding proteins by small biomolecules.Nature reviews. Molecular cell biology · 2026
    Review
  8. Article
  9. Article
  10. Understanding Psychotic Depression.Advances in experimental medicine and biology · 2026
    Review
  11. Article
  12. Article
  13. Review
  14. LncRNA-miRNA‒mRNA Network in Schizophrenia.Journal of molecular neuroscience : MN · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Christopher Y ParkFlatiron Institute, Simons Foundation, New York, NY, USA. cpark@flatironinstitute.org.ORCID http://orcid.org/0000-0002-6219-3886
Jian ZhouFlatiron Institute, Simons Foundation, New York, NY, USA.
Aaron K WongFlatiron Institute, Simons Foundation, New York, NY, USA.
Kathleen M ChenFlatiron Institute, Simons Foundation, New York, NY, USA.ORCID http://orcid.org/0000-0002-7461-9530
Chandra L TheesfeldLewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA.
Robert B DarnellLaboratory of Molecular Neuro-Oncology, The Rockefeller University, New York, NY, USA.
Olga G TroyanskayaFlatiron Institute, Simons Foundation, New York, NY, USA. ogt@cs.princeton.edu.ORCID http://orcid.org/0000-0002-5676-5737
Simons Foundation · USPrinceton University · USHoward Hughes Medical Institute · US

Funding

Pilot Study: POPULATION PHARMACOLOGYU54HL117798 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2016
$18.5M
Combining New Molecular and Informatic Strategies to Find Hidden Ways to Treat Brain DiseaseR35NS097404 · NINDS · ROCKEFELLER UNIVERSITY · PI DARNELL, ROBERT B · 2017 to 2024
$9.0M
lntegration and Visualization of Diverse Biological DataR01GM071966 · NIGMS · PRINCETON UNIVERSITY · PI TROYANSKAYA, OLGA G · 2005 to 2022
$6.4M
Context-Sensitive Search of Human Expression CompendiaR01HG005998 · NHGRI · PRINCETON UNIVERSITY · PI TROYANSKAYA, OLGA G · 2011 to 2013
$1.1M
Howard Hughes Medical InstituteNHGRI NIH HHS R01 HG005998NHLBI NIH HHS U54 HL117798NIAID NIH HHS HHSN272201000054CNIGMS NIH HHS R01 GM071966NINDS NIH HHS R35 NS097404
6 · The paper itself

Abstract

Despite the strong genetic basis of psychiatric disorders, the underlying molecular mechanisms are largely unmapped. RNA-binding proteins (RBPs) are responsible for most post-transcriptional regulation, from splicing to translation to localization. RBPs thus act as key gatekeepers of cellular homeostasis, especially in the brain. However, quantifying the pathogenic contribution of noncoding variants impacting RBP target sites is challenging. Here, we leverage a deep learning approach that can accurately predict the RBP target site dysregulation effects of mutations and discover that RBP dysregulation is a principal contributor to psychiatric disorder risk. RBP dysregulation explains a substantial amount of heritability not captured by large-scale molecular quantitative trait loci studies and has a stronger impact than common coding region variants. We share the genome-wide profiles of RBP dysregulation, which we use to identify DDHD2 as a candidate schizophrenia risk gene. This resource provides a new analytical framework to connect the full range of RNA regulation to complex disease.

Indexed as

3' Untranslated RegionsDeep LearningGene Expression RegulationGene FrequencyGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMental DisordersMutationNuclear Factor 90 ProteinsPeptide Elongation FactorsPhospholipasesPolymorphism, Single NucleotideQuantitative Trait LociRibonucleoprotein, U5 Small NuclearRNA-Binding Proteins3' Untranslated RegionsDDHD2 protein, humanEFTUD2 protein, humanILF3 protein, humanNuclear Factor 90 ProteinsPeptide Elongation FactorsPhospholipasesRibonucleoprotein, U5 Small NuclearRNA-Binding ProteinsRNA HelicasesTrans-ActivatorsUPF1 protein, human

Identifiers

PMID33462483
PMCPMC7886016
OpenAlexW3122552508

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.